Literature DB >> 12048965

Testing of the PHS-ES: a measure of Perimenopausal Health Self-Efficacy.

Susan McClennan Reece1, Gene E Harkless.   

Abstract

This article summarizes the development and psychometric analysis of the Perimenopausal Health Self-Efficacy Scale (PHS-ES) designed to assess women's health promotion self-efficacy related to mid-life changes in health. Items were generated from a qualitative study of HRT decision-making and recommended health promotion activities. The PHS-ES was administered 2 weeks apart to 98 university-based women ages 45 to 64 along with the measures of functional health status, stress, and the self-concept. Internal consistency (alpha = .88 and .90) and test-retest reliabilities (.86) were acceptable. Four factors emerged during factor analysis with 21 of the items explaining 50% of the variance and which were consistent with the conceptual basis of the PHS-ES. The PHS-ES was significantly correlated with functional health status, self-concept, stress, age and body mass index (BMI). In conjunction with stress and BMI, the PHS-ES predicted 50% of the variance of functional health. Further reliability and validity assessments are recommended with more racially and socioeconomically heterogeneous groups of perimenopausal women. It was concluded that the PHS-ES adequately demonstrated reliability and validity in this study.

Entities:  

Mesh:

Year:  2002        PMID: 12048965     DOI: 10.1891/jnum.10.1.15.52549

Source DB:  PubMed          Journal:  J Nurs Meas        ISSN: 1061-3749


  2 in total

1.  Identifying the educational needs of menopausal women: a feasibility study.

Authors:  Kimberlee J Trudeau; Jessica L Ainscough; Meredith Trant; Joan Starker; Tara M Cousineau
Journal:  Womens Health Issues       Date:  2010-12-24

2.  Integrative health care model for climacteric stage women: design of the intervention.

Authors:  Svetlana V Doubova; Patricia Espinosa-Alarcón; Sergio Flores-Hernández; Claudia Infante; Ricardo Pérez-Cuevas
Journal:  BMC Womens Health       Date:  2011-02-20       Impact factor: 2.809

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.